INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER

Detalhes bibliográficos
Autor(a) principal: Adamczyk, Sheila
Data de Publicação: 2023
Outros Autores: César da Silva, Junio, Jaqueline Pereira de Souza, Silvia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Health and Society
Texto Completo: https://www.periodicojs.com.br/index.php/hs/article/view/1443
Resumo: Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease.
id IEPP-2_6a59bbf9ce3819e4a368f5e78519feb1
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1443
network_acronym_str IEPP-2
network_name_str Health and Society
repository_id_str
spelling INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTEREmbolism Pulmonary. Respiratory Distress Syndrome. COVID-19Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease.Editora Acadêmica Periodicojs2023-07-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.periodicojs.com.br/index.php/hs/article/view/144310.51249/hs.v3i04.1443Health and Society; Vol. 3 No. 04 (2023); 78 - 94Health and Society; v. 3 n. 04 (2023); 78 - 942763-572410.51249/hs.v3i04reponame:Health and Societyinstname:Instituto de Ensino e Pesquisa Periodicojsinstacron:IEPPporhttps://www.periodicojs.com.br/index.php/hs/article/view/1443/1267Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAdamczyk, SheilaCésar da Silva, Junio Jaqueline Pereira de Souza, Silvia 2023-07-18T00:11:22Zoai:ojs.pkp.sfu.ca:article/1443Revistahttps://www.periodicojs.com.br/index.php/hs/PRIhttps://www.periodicojs.com.br/index.php/hs/oaijournalofhealthandsociety@gmail.com || periodicojs@gmail.com2763-57242763-5724opendoar:2023-07-18T00:11:22Health and Society - Instituto de Ensino e Pesquisa Periodicojsfalse
dc.title.none.fl_str_mv INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
title INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
spellingShingle INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
Adamczyk, Sheila
Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19
title_short INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
title_full INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
title_fullStr INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
title_full_unstemmed INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
title_sort INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
author Adamczyk, Sheila
author_facet Adamczyk, Sheila
César da Silva, Junio
Jaqueline Pereira de Souza, Silvia
author_role author
author2 César da Silva, Junio
Jaqueline Pereira de Souza, Silvia
author2_role author
author
dc.contributor.author.fl_str_mv Adamczyk, Sheila
César da Silva, Junio
Jaqueline Pereira de Souza, Silvia
dc.subject.por.fl_str_mv Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19
topic Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19
description Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.periodicojs.com.br/index.php/hs/article/view/1443
10.51249/hs.v3i04.1443
url https://www.periodicojs.com.br/index.php/hs/article/view/1443
identifier_str_mv 10.51249/hs.v3i04.1443
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.periodicojs.com.br/index.php/hs/article/view/1443/1267
dc.rights.driver.fl_str_mv Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silva
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silva
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Editora Acadêmica Periodicojs
publisher.none.fl_str_mv Editora Acadêmica Periodicojs
dc.source.none.fl_str_mv Health and Society; Vol. 3 No. 04 (2023); 78 - 94
Health and Society; v. 3 n. 04 (2023); 78 - 94
2763-5724
10.51249/hs.v3i04
reponame:Health and Society
instname:Instituto de Ensino e Pesquisa Periodicojs
instacron:IEPP
instname_str Instituto de Ensino e Pesquisa Periodicojs
instacron_str IEPP
institution IEPP
reponame_str Health and Society
collection Health and Society
repository.name.fl_str_mv Health and Society - Instituto de Ensino e Pesquisa Periodicojs
repository.mail.fl_str_mv journalofhealthandsociety@gmail.com || periodicojs@gmail.com
_version_ 1797047895015292928